Matches in Wikidata for { <http://www.wikidata.org/entity/Q71697221> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q71697221 description "artículu científicu espublizáu n'ochobre de 1996" @default.
- Q71697221 description "im Oktober 1996 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71697221 description "scientific article published on 01 October 1996" @default.
- Q71697221 description "wetenschappelijk artikel" @default.
- Q71697221 description "наукова стаття, опублікована в жовтні 1996" @default.
- Q71697221 name "Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study Group" @default.
- Q71697221 name "Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study Group" @default.
- Q71697221 type Item @default.
- Q71697221 label "Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study Group" @default.
- Q71697221 label "Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study Group" @default.
- Q71697221 prefLabel "Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study Group" @default.
- Q71697221 prefLabel "Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study Group" @default.
- Q71697221 P1433 Q71697221-944DFBF5-72E2-4530-A60A-BEBE3164AD5C @default.
- Q71697221 P1476 Q71697221-BDEC72A6-FAF9-48B5-BDC1-856AA1427149 @default.
- Q71697221 P2093 Q71697221-2C5A1338-B3BE-4B34-AE1D-B7D838AB66E1 @default.
- Q71697221 P2093 Q71697221-37310B38-05F4-49E5-AA39-E06839508B4D @default.
- Q71697221 P2093 Q71697221-5A8BE0C1-738E-49F6-AB5A-EE6FCCA66352 @default.
- Q71697221 P2093 Q71697221-7CFF9A6E-FA5B-4E39-8CBE-B58FCAB7816B @default.
- Q71697221 P2093 Q71697221-ABC85C4C-285F-487C-9388-41503A50A724 @default.
- Q71697221 P2093 Q71697221-D9A17BFE-A27D-43F1-8C35-23C1E57D9C98 @default.
- Q71697221 P2093 Q71697221-E39A04A5-4C76-4583-B1F2-5C542FAAFA2E @default.
- Q71697221 P304 Q71697221-81F34F3A-7E7F-4843-BD29-9BF9D99D377C @default.
- Q71697221 P31 Q71697221-037F7EC8-5C00-4E8C-A36C-3C2344EFCBFD @default.
- Q71697221 P356 Q71697221-09B4BEEE-D029-4485-8C08-FFAB3D844E90 @default.
- Q71697221 P433 Q71697221-A3AFA2F9-CA75-4ECA-8E13-47689A839AE6 @default.
- Q71697221 P478 Q71697221-F83DD3FA-9FBF-4455-A78D-ECB4E25F0AE4 @default.
- Q71697221 P577 Q71697221-22D80065-62FF-454B-8917-AA7AB64A15D3 @default.
- Q71697221 P698 Q71697221-11FC854D-5B5C-4160-9271-31608FC436F9 @default.
- Q71697221 P921 Q71697221-251EDD74-432D-4C7C-89B2-4EC66D2DC40E @default.
- Q71697221 P921 Q71697221-46B87A2E-3CC2-47ED-AF2D-EA81D0EB7656 @default.
- Q71697221 P921 Q71697221-D5C500E0-DB9C-41E4-A896-788AD556A126 @default.
- Q71697221 P356 (SICI)1097-0045(199610)29:4%3C199::AID-PROS1%3E3.0.CO;2-7 @default.
- Q71697221 P698 8876703 @default.
- Q71697221 P1433 Q7758608 @default.
- Q71697221 P1476 "Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study Group" @default.
- Q71697221 P2093 "Bono AV" @default.
- Q71697221 P2093 "Eickenberg HU" @default.
- Q71697221 P2093 "Fletcher MS" @default.
- Q71697221 P2093 "Fourcade RO" @default.
- Q71697221 P2093 "Radlmaier A" @default.
- Q71697221 P2093 "Reis Santos JM" @default.
- Q71697221 P2093 "van Aubel OG" @default.
- Q71697221 P304 "199-208" @default.
- Q71697221 P31 Q13442814 @default.
- Q71697221 P356 "10.1002/(SICI)1097-0045(199610)29:4<199::AID-PROS1>3.0.CO;2-7" @default.
- Q71697221 P433 "4" @default.
- Q71697221 P478 "29" @default.
- Q71697221 P577 "1996-10-01T00:00:00Z" @default.
- Q71697221 P698 "8876703" @default.
- Q71697221 P921 Q269829 @default.
- Q71697221 P921 Q277954 @default.
- Q71697221 P921 Q506659 @default.